DiagnosTear says TeaRx Red Eye study shows 89% sensitivity, 83.3% specificity vs ELISA for tear IgE detection

PUBT · 2d ago
DiagnosTear says TeaRx Red Eye study shows 89% sensitivity, 83.3% specificity vs ELISA for tear IgE detection
  • DiagnosTear reported final results from a clinical study of TeaRx Red Eye, a point-of-care test for red-eye diagnosis.
  • The study showed the test could reliably detect a tear-based allergy biomarker, supporting differentiation of allergic conjunctivitis from other common causes.
  • Data were analyzed from 93 tear samples from 31 subjects, collected before and following feline-allergen provocation.
  • Results add support for the program’s FDA pre-submission work as the company advances toward broader validation and U.S. commercialization.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Diagnostear Technologies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609100830NEWSFILECNPR____20260910_313747_1) on September 10, 2026, and is solely responsible for the information contained therein.